✦ LIBER ✦

Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations

✍ Scribed by Mallo, Mar; del Rey, Mónica; Ibáñez, Mariam; Calasanz, Mª José; Arenillas, Leonor; Larráyoz, Mª José; Pedro, Carmen; Jerez, Andrés; Maciejewski, Jaroslaw; Costa, Dolors; Nomdedeu, Meritxell; Diez-Campelo, María; Lumbreras, Eva; González-Martínez, Teresa; Marugán, Isabel; Such, Esperanza; Cervera, José; Cigudosa, Juan C.; Álvarez, Sara; Florensa, Lourdes; Hernández, Jesús Mª; Solé, Francesc

Book ID: 125431646
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 292 KB
Volume: 162
Category: Article
ISSN: 0007-1048
DOI: 10.1111/bjh.12354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to lenalidomide in patients wit

Response to lenalidomide in patients with myelodysplastic syndrome with deletion 5q: clinical and cytogenetic analysis of a single centre series

✍ Rita Coutinho; Dolors Costa; Ana Carrió; Concha Muñoz; Ana Vidal; Mohammed Belka 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 64 KB

Haematological and cytogenetic responses

Haematological and cytogenetic responses after only 7 days of Lenalidomide in a patient with myelodysplastic syndrome and chromosome 5q deletion

✍ Sondes Hadiji Mseddi; Faten Kallel; Olfa Kassar; Moez Elloumi; Ines Jedidi; Hali 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Efficacy of lenalidomide in a patient wi

Efficacy of lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2V617F mutation

✍ Meritxell Nomdedeu; Margherita Maffioli; Xavier Calvo; Alejandra Martínez-Trillo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Hematologic and cytogenetic response to

Hematologic and cytogenetic response to lenalidomide monotherapy in acute myeloid leukemia arising from JAK2V617F positive, del(5)(q13q33) myelodysplastic syndrome

✍ Mesa, R A; Tefferi, A; Li, C-Yang; Steensma, D P 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB

Role of lenalidomide in the management o

Role of lenalidomide in the management of myelodysplastic syndromes with del(5q) associated with pure red cell aplasia (PRCA)

✍ Cerchione, Claudio; Catalano, Lucio; Cerciello, Giuseppe; Avilia, Simona; Picard 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 590 KB

Cytogenetic and molecular predictors of

Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide

✍ Yuka Sugimoto; Mikkael A Sekeres; Hideki Makishima; Fabiola Traina; Valeria Visc 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 262 KB